General description
Non-metabolizable derivative of glucose that can be carried by the glucose carrier in human erythrocytes. An indirect inhibitor of hexokinase. Reported to reduce the incidence of doxorubicin-induced apoptosis.
Legal Information
CALBIOCHEM is a registered trademark of Merck KGaA, Darmstadt, Germany
Other Notes
Thakkar, N.S., and Potten, C.S. 1993. Cancer Res. 53, 2057.
Packaging
1 g in Glass bottle
Reconstitution
Following reconstitution, refrigerate (4°C). Stock solutions are stable for up to 6 months at 4°C.
Warning
Toxicity: Standard Handling (A)
This product has met the following criteria to qualify for the following awards: